NeuroMetrix Stock News

It's time for a market update and we're diving into why stocks are down on Tuesday and there's plenty of reasons for today's dip. The post Market Update: Why Are Stocks Down Tuesday?

NeuroMetrix (NURO) stock is rocketing higher on Tuesday thanks to the FDA granting it Breakthrough Designation for one of its devices. The post NURO Stock: Why NeuroMetrix Investors Are Feeling No Pai

The FDA has granted Breakthrough Designation to NeuroMetrix Inc's (NASDAQ:NURO) Quell technology for reducing moderate to severe symptoms of chemotherapy-induced peripheral neuropathy (CIPN) that

Webull penny stocks to watch this week. The post Best Penny Stocks To Buy Now?

WOBURN, Mass., Jan. 05, 2022 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that Shai N. Gozani M.D., Ph.D., President and Chief Executive Officer, will be presenting at the H.

NeuroMetrix (NASDAQ:NURO) and Paragon 28 (NYSE:FNA) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, earnings, profitability, risk and dividends. Earnings & Valuation This table compares NeuroMetrix and Paragon 28s gross revenue, earnings per share and []

Key Companies in Wearable Medical Devices Market are BD , Ypsomed , Fitbit, Inc. , Apple Inc. , Sonova , NeuroMetrix, Inc. , SAMSUNG , Omron Healthcare, Inc. , AiQ Smart Clothing , Koninklijke Philips N.V. , Other Prominent Player Key Companies in Wearable Medical Devices Market are BD , Ypsomed , Fitbit, Inc. , Apple Inc. , Sonova , NeuroMetrix, Inc. , SAMSUNG , Omron Healthcare, Inc. , AiQ Smart Clothing , Koninklijke Philips N.V. , Other Prominent Player

NeuroMetrix, Inc. (NASDAQ:NURO) was the target of a large decrease in short interest during the month of November. As of November 15th, there was short interest totalling 29,600 shares, a decrease of 92.2% from the October 31st total of 378,600 shares. Based on an average daily trading volume, of 2,920,000 shares, the short-interest ratio is []

Electrotherapy Devices market report performs thorough analysis of the potential of the market in the present and the future prospects from various angles. The report provides segmentation of the global market on the basis of technology, application, product, and region.

DUBLIN, Nov. 18, 2021 /PRNewswire/ -- The "Pain Management Devices Market - Forecasts from 2021 to 2026" report has been added to ResearchAndMarkets.com''s offering. The global pain management devices market is expected to grow at a compound annual growth rate of 11.04% over the forecast

NeuroMetrix, Inc. (NURO) CEO Dr. Shai Gozani on Q3 2021 Results - Earnings Call Transcript

WOBURN, Mass., Oct. 14, 2021 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it plans to issue its 2021 third quarter financial results before the opening of the market on Oc

The stock price of Neurometrix Inc (NASDAQ: NURO) increased by over 10% pre-market today. This is why it happened.

WOBURN, Mass., Oct. 06, 2021 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today announced that it has submitted a De Novo request to the U.S. Food and Drug Administration (FDA) for Quell as a

WOBURN, Mass., Oct. 05, 2021 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today announced that it has joined the Center to Stream Healthcare In Place (C2SHIP) as an industry partner.